Dr Reddys launches OTC Nicotine Polacrilex Lozenges in US Ruchika Sharma15 July 2020 11:01 AM ISTDr Reddy’s Nicotine Polacrilex Lozenges are available in multiple pack sizes based on consumers’ requirements.
NPPA fixes retail price of 14 formulations; Details Farhat Nasim4 July 2020 3:36 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India...
Dr Reddy's earmarks capex of Rs 1000 crore, expects to unveil 25 products in US this fiscal Ruchika Sharma29 Jun 2020 11:57 AM IST"On a full-year basis (2019-20), we launched 27 products, including four re-launch of the earlier discontinued products. We expect the new launches...
Merck goes against Dr Reddys alleging patent infringement of diabetes drug Januvia, Janumet Farhat Nasim28 Jun 2020 10:45 AM ISTMerck in its petition filed on June 23, said Dr Reddys had submitted ANDAs (abbreviated new drug application) to the US FDA seeking approval from the...
Indian Pharma Industries likely to continue Chinese imports till feasible alternatives emerge Ruchika Sharma28 Jun 2020 9:15 AM ISTHe, however, added that the government has addressed the need to reduce import dependence by bringing in the bulk drug and medical devices policy.
COVID-19 Impact: Dr Reddys, Wockhardt alter Rs 1850 crore deal terms Farhat Nasim11 Jun 2020 11:06 AM ISTSubsequently, through an amendment to the BTA, Dr.Reddys and Wockhardt that 1,483 crore would be paid on the date of closing the deal consideration,...
DoP directs NPPA to verify documentary proof submitted by Cipla for Budesonide Farhat Nasim7 Jun 2020 1:09 PM ISTNew Delhi: Upholding the order of Delhi High Court to re-examine of the review applications moved by Cipla Ltd., the Department of...
